Single Use Instruments News Today

WALTHAM, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- BVI, a diversified global ophthalmic device company, today announced it has completed enrollment of its U.S. Investigational Device Exemption (IDE) clinical

(1) First of a planned family of TORIC IOLs offered on BVIs proprietary G-Free hydrophobic material Features the unique Double C-loop haptic platform - specifically designed for improved stability required by TORIC IOLs for long-term, accurate astigmatism correction Of 3,649 papers reviewed, 31 studies from 32 publications met the inclusion criteria of this review. Preexisting astigmatism ≥1D was present in up to 47% of cataract eyes. 1 WALTHAM, MA / ACCESSWIRE / February 2, 2021 / BVI, the m...